The use of lisuride in the treatment of multiple system atrophy with autonomic failure (Shy-Drager syndrome).

In a controlled trial lisuride, an ergolene derivative with dopamine receptor agonist properties was given maximum tolerated doses (2.4 mg/day) to seven patients with multiple system atrophy with autonomic failure (Shy-Drager syndrome). Improvement in Parkinsonian features occurred in only one patie...

Descripció completa

Dades bibliogràfiques

Publicat a:	J Neurol Neurosurg Psychiatry
Autors principals:	Lees, A J, Bannister, R
Format:	Artigo
Idioma:	Inglês
Publicat:	BMJ Publishing Group 1981
Matèries:	Research Article
Accés en línia:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC490960/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7241162/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/jnnp.44.4.347
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!